3rd Quarter - Report

MEDICAL DEVICE MANUFACTURERS ASSOCIATION for MEDICAL DEVICE MANUFACTURERS ASSOCIATION

Firm
Client
Income
—
Expenses
$300,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Issues relating to the STRONGER Patents Act and Section 101 reform

LobbyistCovered position, as disclosed
DONALD CLAYTON HALL —
MARK LEAHEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO)

Health Issues HCR

Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act

LobbyistCovered position, as disclosed
DONALD CLAYTON HALL —
MARK LEAHEY —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5662 (119th), H.R. 2369 (119th), H.R. 3723 (119th)

Medicare/Medicaid MMM

Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare

LobbyistCovered position, as disclosed
DONALD CLAYTON HALL —
MARK LEAHEY —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 5343 (119th), S. 1717 (119th)

Taxation/Internal Revenue Code TAX

Issues related to R&D tax credit, bonus depreciation, and interest deductability

LobbyistCovered position, as disclosed
DONALD CLAYTON HALL —
MARK LEAHEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Issues related to global trade and tariffs Issues related to United States-Mexico-Canada Agreement (USMCA)

LobbyistCovered position, as disclosed
DONALD CLAYTON HALL —
MARK LEAHEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Issues related to appropriations and user fee funding for the Food and Drug Administration

LobbyistCovered position, as disclosed
DONALD CLAYTON HALL —
MARK LEAHEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Small Business SMB

Issues related to the reauthorization of the Small Business Innovation Research (SBIR) Program

LobbyistCovered position, as disclosed
DONALD CLAYTON HALL —
MARK LEAHEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.